Clinical Trial Update: Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating personalized tumor vaccines in combination with a PD-L1 blocker for resectable pancreatic cancer; the trial is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• PD-L1 blocker
• Personalized Tumor Vaccines (PCVs)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING